According to research report the global spirometer market was valued at $799 million in 2020 and is expected to reach $1,285 million by 2025, growing at a compound annual growth rate (CAGR) of 11.1% during the forecast period. This growth is largely driven by the rising global incidence of respiratory diseases, an aging population, and technological advancements in spirometer devices.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18015659
Respiratory diseases are a major cause of death globally, accounting for five of the top 30 fatal diseases worldwide. Chronic obstructive pulmonary disease (COPD) ranks as the third leading cause of mortality. Early diagnosis and monitoring of respiratory diseases is crucial for effective treatment and avoiding complications. Spirometry plays a vital role in evaluating lung function and determining disease severity. The rising burden of respiratory illness will spur demand for spirometers going forward. Additionally, since lung capacity deteriorates with age, growth in the aging population will drive the need for testing.
Emerging economies present significant expansion opportunities for spirometer manufacturers. Many developing countries suffer extremely high levels of air pollution – 14 of the 20 most polluted cities globally are located in India. However, utilization of spirometers is still relatively low in these nations due to limited healthcare access and resources. As emerging economies grow their healthcare infrastructure and focus more on prevention, the spirometer market is likely to flourish in countries such as India, China, Brazil and South Africa.
A key challenge facing the global spirometer market is the time-intensive nature of the diagnostic tests. Patients are required to forcefully blow into the spirometer mouthpiece for up to six seconds, with the procedure repeated three times for accuracy, followed by a repeatability test. This process can be physically demanding and impacts patient compliance for follow-up assessments. Technological improvements to simplify testing could help overcome this barrier.
By product, spirometer devices accounted for the majority share of total market revenue in 2019. Flow-sensing spirometers are the dominant segment, owing to accuracy, technological sophistication and rising adoption. Based on application, testing for COPD commanded the greatest portion of the spirometer industry due to the high prevalence of the condition worldwide and the importance of spirometry for diagnosis and monitoring.
Geographically, North America was the largest regional market, holding the greatest percentage of global spirometer sales. Growth drivers include elevated incidence of lung disease, favorable insurance coverage and reimbursement policies, and rising use of advanced medical equipment. Europe was the second largest market, followed by the Asia Pacific region which is poised for rapid expansion in the future.
Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=18015659
Overall, the spirometer industry displays robust growth prospects globally, driven by an aging population and increasing respiratory illness tied to risk factors such as smoking, pollution and lifestyle changes. Technological improvements in portable and connected devices provide opportunities to expand access and simplify diagnostic testing for patients.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
